Common Drug Targets *
► Pegylated Interferon
*Note: Drugs listed above are not an all encompassing list
Cancer Genomics (CGx)
Why Cancer Genomics?
What if there was a way to screen for hereditary cancer types? QTLD's Cancer Genomics panel delivers a comprehensive report on how genetics can impact the patient's response to specific medications. Our diagnostic comprehensive PGx panel can help a provider customize medication plans to a specific patient's genetic makeup. Ultimately, this can help reduce patient hospitalizations from adverse drug reactions.
Understand Your Patient's Drug Sensitivity
Pharmacogenomics can help determine if a patient is metabolizing medication at a high, moderate, or low rate.
► Low Metabolism: PGx can help REDUCE Adverse Drug Reactions from Toxicity - Excessive amounts of medications can accumulate in bloodstream lead to an adverse drug reaction.
► Moderate to High Metabolism: PGx can help UNDERSTAND if the patient is not absorbing their medication in the bloodstream at a rate which leads to a therapeutic effect.
► PGx helps providers identify patients with a possible hypersensitive response to normal amounts of prescribed medication which can help reduce adverse drug reactions before giving the patient a customized medication plan.
Our Offering & Key Benefits
► Robust panel with 30+ genes
► Created for providers to better understand their patient before prescribing medication.
► PGx leads to evidence based, actionable genetic data
• One-Time Genetic Test for Each Patient
• Lower Healthcare Costs and Improve Outcomes
• Genetic Data Adds a Personalized Experience for Your Patients
Our “Priority + Program”
► Open saturdays & emergency hours
► Dedicated patient hotline for all EOB/billing questions
► Internal FTE’s (at lab) for office/facility support
► Best-in-Class LIMS system
► No cost for EMR integration